VP, Director of Oncology Services
Ascension
Pearland, Texas, United States
Dr. Thomas Aloia, MD, MHCM joined the Ascension Leadership Team
on January 1, 2021, as Vice President, Director of Oncology Services
reporting to Richard Fogel, MD, Chief Clinical Officer (CCO) with Clinical &
Network Services (CNS).
He is a trained Hepatobiliary Surgical Oncologist, formerly working as a
Professor of Surgical Oncology in the Gastrointestinal Center at the
University of Texas MD Anderson Cancer Center.
Dr. Aloia received his medical degree from the University of California –
Los Angeles Geffen School of Medicine. His postgraduate training included
a general and thoracic surgery residency at Duke University Medical
Center and fellowships in Surgical Oncology at MD Anderson and
Hepatobiliary Surgery/Liver Transplantation at the Paul Brousse Hospital
in Paris, France. He has received a Certificate in Healthcare Management
from Rice University Jones Business School and Master’s Degree in Health
Care Management from the Harvard T.H. Chan School of Public Health.
Dr. Aloia’s clinical expertise is in hepatobiliary surgery, gastrointestinal
surgical oncology, minimally invasive surgery and liver transplantation
surgery. He has published over 250 peer-reviewed manuscripts in the
focus areas of surgical outcomes, GI oncology, enhanced recovery and
value-based healthcare. He has served as an ad hoc reviewer for multiple
medical and surgical journals and is on the editorial board of Annals of
Surgery and the Annals of Surgical Oncology.
At MDACC he served multiple administrative roles in the areas of patient
safety, quality, and outcomes, including Gastrointestinal Disease Center
Medical Director, Executive Director of Network Outcomes, Chief Quality
Officer and Head of the Institute for Cancer Care Innovation.
Email: Thomas.Aloia@Ascension.org
Motto: With a Plan, Comes Hope!
Disclosure information not submitted.
Thursday, March 10, 2022
4:49 PM – 4:57 PM CST
Thursday, March 10, 2022
5:04 PM – 5:15 PM CST